SCHEMBL30801797

SCHEMBL30801797

N#Cc1cccc(-c2cc(N3CCN4CCNC[C@@H]4C3=O)ncn2)c1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.47
CYP1A2 P05177 3/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C19 P33261 2/20 0.46
HSD17B10 Q99714 2/20 0.46
ALOX15 P16050 1/20 0.46
DPP4 P27487 2/20 0.45
USP30 Q70CQ3 2/20 0.42
CLK4 Q9HAZ1 2/20 0.40
LRRK2 Q5S007 9/20 0.40
XDH P47989 1/20 0.38
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801870 0.86 GRM5 (0.48) GRM5CYP1A2DPP4USP30LRRK2
SCHEMBL30801868 0.86 DPP4 (0.42) GRM5CYP1A2CYP3A4CYP2C19DPP4
SCHEMBL23573922 0.85 DPP4 (0.49) GRM5CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL23573924 0.85 DPP4 (0.49) GRM5CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL30801790 0.81 USP30 (0.43) CYP1A2CYP3A4HSD17B10ALOX15USP30
SCHEMBL30801795 0.81 USP30 (0.43) CYP1A2CYP3A4HSD17B10ALOX15USP30
SCHEMBL30801758 0.81 DPP4 (0.39) CYP1A2HSD17B10DPP4USP30ALDH1A1
SCHEMBL30801771 0.81 SCD (0.43) CYP1A2CYP3A4HSD17B10USP30CLK4
SCHEMBL30801748 0.81 USP30 (0.39) USP30LRRK2XDH
SCHEMBL30801741 0.81 SCD (0.43) CYP1A2CYP3A4HSD17B10USP30CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793997-B1 FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30 INHIBITORS FORMA THERAPEUTICS INC (US) 2024-03-13 EP claimed